Detailansicht

Wissensnetz

Person

Giuseppe Mancia

Kardiologe

Name	Giuseppe Mancia
Ort	Monza (Wirkungsort) Italien
Geschlecht	männlich
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Kardiologe (charakteristischer Beruf) Rheumatologe
Variante	G. Mancia
Weitere Angaben	Leiter der Abteilung für Innere Medizin, San Gerardo-Krankenhaus, Monza. Forschungsschwerpunkte: Pathophysiologie, klinische Pharmakologie, Therapie von Bluthochdruck, Herzinsuffizienz
Quelle	Homepage Radcliffe Cardiology: http://www.touchcardiology.com/authors/giuseppe-mancia (Stand: 20.03.2018)
Datensatztyp	Person
GND-Nummer	121717364
Datensatz-ID	121717364
Beteiligt an alle anzeigen Hypertension and Heart Failure : Epidemiology, Mechanisms and Treatment Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control History of lower-limb complications and risk of cancer death in people with type 2 diabetes Renal denervation in high-risk patients with hypertension The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study Associations between body mass index and the risk of renal events in patients with type 2 diabetes Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes Italian Society of Hypertension Guidelines for Conventional and Automated Blood Pressure Measurement in the Office, at Home and Over 24 Hours Cardiorenal Syndrome : Mechanisms, Risk and Treatment Cardiovascular protection for all individuals at high risk: evidence-based best practice Aggiorn@rsi in Rete Ipertensione arteriosa : attualita dal Web, trial clinici in rete, liste, gruppi e canali di discussione, videoconferenze

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Giuseppe Mancia

Hypertension and Heart Failure : Epidemiology, Mechanisms and Treatment

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk

Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range

Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control

Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control

History of lower-limb complications and risk of cancer death in people with type 2 diabetes

Renal denervation in high-risk patients with hypertension

The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study

Associations between body mass index and the risk of renal events in patients with type 2 diabetes

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes

Italian Society of Hypertension Guidelines for Conventional and Automated Blood Pressure Measurement in the Office, at Home and Over 24 Hours

Cardiorenal Syndrome : Mechanisms, Risk and Treatment

Cardiovascular protection for all individuals at high risk: evidence-based best practice

Aggiorn@rsi in Rete